42.61 USD
↘ 1.12 (2.56%)LIVE (AS OF 02:25 PM EST)
Rigel Pharmaceuticals Inc. (New) (RIGL) is currently trading at $42.61. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, exceptional Return on Equity (69.0%) and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 16, 2026.